evocatal

evocatal

A German Industrial Biotechnology Company, is focusing on the development and production of industrial enzymes. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€14—21m (Dealroom.co estimates Jun 2013.)
Company register number HRB 56230 (Düsseldorf)
Monheim am Rhein Nordrhein-Westfalen (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2017201820192020202120222023
Revenues-2.0m1.3m1.2m1.6m-1.4m
% growth--(36 %)(7 %)33 %--
Profit(3.2m)(<1m)(<1m)<1m<1m(<1m)-
% profit margin-(21 %)(58 %)22 %10 %--

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

N/A

Seed

N/A

Seed
N/A

€2.0m

Series B
N/A

€3.5m

Series B
Total Funding€5.5m

Recent News about evocatal

Edit
More about evocatalinfo icon
Edit

Evoxx Technologies GmbH, now a part of Advanced Enzyme Technologies Limited, is a specialty biotech company focused on the research, development, and manufacturing of enzymes and probiotics. The company serves a diverse range of clients including healthcare providers, agricultural businesses, and industrial manufacturers. Operating in the industrial biotechnology market, Evoxx Technologies aims to provide side effect-free healthcare solutions, enhance animal nutrition for farmers, and replace traditional industrial processes with enzyme-based alternatives. The business model revolves around the development and commercialization of proprietary enzyme and probiotic products, generating revenue through product sales and licensing agreements. Evoxx Technologies leverages its expertise in biotechnology to deliver innovative solutions that meet the evolving needs of its clients.

Keywords: enzymes, probiotics, healthcare, agriculture, industrial biotechnology, enzyme-based processes, animal nutrition, proprietary products, biotech solutions, Advanced Enzyme Technologies.